
Sign up to save your podcasts
Or


Gavin and Jessamy are joined by Oksana Pyzik (UCL, Fight The Fakes Alliance) to discuss how Ozempic/Wegovy/semaglutide works, what becoming mainstream means for our understanding of obesity and public health, and how demand is fuelling an unregulated black market in the drugs.
Send us your feedback!
Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancet
Check out all the podcasts from The Lancet Group:
https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancet
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
By The Lancet Group5
2121 ratings
Gavin and Jessamy are joined by Oksana Pyzik (UCL, Fight The Fakes Alliance) to discuss how Ozempic/Wegovy/semaglutide works, what becoming mainstream means for our understanding of obesity and public health, and how demand is fuelling an unregulated black market in the drugs.
Send us your feedback!
Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancet
Check out all the podcasts from The Lancet Group:
https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancet
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

11,106 Listeners

7,938 Listeners

321 Listeners

2,051 Listeners

503 Listeners

752 Listeners

411 Listeners

426 Listeners

817 Listeners

1,404 Listeners

840 Listeners

364 Listeners

2,588 Listeners

4,814 Listeners

631 Listeners

0 Listeners

0 Listeners

3 Listeners

1 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners